Drug Allergy Labels Lost in Translation: From Patient to Charts and Backwards
Allergy and Immunology
Journal of Allergy and Clinical Immunology: In Practice
The current method of defining, reporting, assessment, labeling, delabeling, and reconciliation of adverse drug reactions (ADRs), and specifically immunologically mediated drug hypersensitivity reactions (HSRs), in electronic health records (EHRs) is inadequate and compromises care quality and safety. It is critical to accurately and succinctly report the signs and symptoms associated with ADRs and suspected HSRs to enable clinicians to determine the plausible reaction type and help guide appropriate future management plans. Despite the current limitations of the EHR allergy module, we must encourage improved clinical documentation and demand technological improvements. Telehealth methods have been shown to be valuable in the assessment of ADRs and HSRs, particularly in the case of penicillin allergy evaluation and delabeling. The implementation, assessment, and refinement of advanced technologies, including clinical informatics and artificial intelligence, along with continued education of health care providers have potential to improve EHR documentation and communication, thereby advancing patient safety efforts.
Ramsey, Allison; Macy, Eric; Chiriac, Anca-Mirela; and Blumenthal, Kimberly G., "Drug Allergy Labels Lost in Translation: From Patient to Charts and Backwards" (2021). Rochester Regional Health authored publications and proceedings. 191.